跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DequadinAB (Orange) - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
DequadinAB (Orange)
Approved
STANDARD
DequadinAB (Orange)
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dc427fe87b7645f4
Company
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Type
Standard
Approval Details
Approval Id
dc427fe87b7645f4
Drug Approval Philippines Name
DequadinAB (Orange)
Product Name
DequadinAB (Orange)
Registration Number
DRHR-1898
Brand Name
DequadinAB (Orange)
Generic Name
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
Dosage Form
Lozenge
Dosage Strength
1.2 mg/0.6 mg
Manufacturer
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Importer
iNova Pharma Philippines Inc.
Distributor
iNova Pharma Philippines Inc.
Issuance Date
28 April 2024
Expiry Date
19 March 2029
Pharmacologic Category
Antiseptic
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dc427fe87b7645f4
Type
Standard
Back to Philippines FDA Approvals